House MG. Commentary on "Neoadjuvant therapy versus upfront surgery for resectable
pancreatic cancer: updated systematic review, individual-patient-data
meta-analysis and trial sequential analysis of randomised controlled trials". Surgery 2026 Mar 6:110124. doi: 10.1016/j.surg.2026.110124.
PMID: 41794621
|